{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:43:39Z","timestamp":1791323019943,"version":"4.3.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominantly inherited neurodegenerative disease, which belongs to the trinucleotide repeat disease group with a CAG repeat expansion in exon 1 of the\n                    <jats:italic>ATXN2<\/jats:italic>\n                    gene resulting in an ataxin-2 protein with an expanded polyglutamine (polyQ)-stretch. The disease is late manifesting leading to early death. Today, therapeutic interventions to cure the disease or even to decelerate disease progression are not available yet. Furthermore, primary readout parameter for disease progression and therapeutic intervention studies are limited. Thus, there is an urgent need for quantifiable molecular biomarkers such as ataxin-2 becoming even more important due to numerous potential protein-lowering therapeutic intervention strategies. The aim of this study was to establish a sensitive technique to measure the amount of soluble polyQ-expanded ataxin-2 in human biofluids to evaluate ataxin-2 protein levels as prognostic and\/or therapeutic biomarker in SCA2. Time-resolved fluorescence energy transfer (TR-FRET) was used to establish a polyQ-expanded ataxin-2-specific immunoassay. Two different ataxin-2 antibodies and two different polyQ-binding antibodies were validated in three different concentrations and tested in cellular and animal tissue as well as in human cell lines, comparing different buffer conditions to evaluate the best assay conditions. We established a TR-FRET-based immunoassay for soluble polyQ-expanded ataxin-2 and validated measurements in human cell lines including iPSC-derived cortical neurons. Additionally, our immunoassay was sensitive enough to monitor small ataxin-2 expression changes by siRNA or starvation treatment. We successfully established the first sensitive ataxin-2 immunoassay to measure specifically soluble polyQ-expanded ataxin-2 in human biomaterials.\n                  <\/jats:p>","DOI":"10.1007\/s12035-023-03294-y","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T17:16:52Z","timestamp":1679851012000},"page":"3553-3567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["TR-FRET-Based Immunoassay to Measure Ataxin-2 as a Target Engagement Marker in Spinocerebellar Ataxia Type 2"],"prefix":"10.1007","volume":"60","author":[{"given":"Jessica","family":"Bux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesli Ece","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isa-Maria","family":"Klink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1022-7482","authenticated-orcid":false,"given":"Stefan","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthis","family":"Synofzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7774-5025","authenticated-orcid":false,"given":"Ludger","family":"Sch\u00f6ls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Auburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7011-1369","authenticated-orcid":false,"given":"Olaf","family":"Riess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4973-0923","authenticated-orcid":false,"given":"Jeannette","family":"H\u00fcbener-Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,9]]},"reference":[{"issue":"3","key":"3294_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/ng1196-277","volume":"14","author":"K Sanpei","year":"1996","unstructured":"Sanpei K, Takano H, Igarashi S, Sato T et al (1996) Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique. DIRECT. Nat Genet 14(3):277\u2013284. https:\/\/doi.org\/10.1038\/ng1196-277","journal-title":"DIRECT. Nat Genet"},{"issue":"3","key":"3294_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ng0793-295","volume":"4","author":"S Gispert","year":"1993","unstructured":"Gispert S, Twells R, Orozco G, Brice A et al (1993) Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1. Nat Genet 4(3):295\u2013299. https:\/\/doi.org\/10.1038\/ng0793-295","journal-title":"Nat Genet"},{"issue":"3","key":"3294_CR3","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/humu.20075","volume":"24","author":"K Sobczak","year":"2004","unstructured":"Sobczak K, Krzyzosiak WJ (2004) Patterns of CAG repeat interruptions in SCA1 and SCA2 genes in relation to repeat instability. Hum Mutat 24(3):236\u2013247. https:\/\/doi.org\/10.1002\/humu.20075","journal-title":"Hum Mutat"},{"issue":"7310","key":"3294_CR4","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature09320","volume":"466","author":"AC Elden","year":"2010","unstructured":"Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS et al (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466(7310):1069\u20131075. https:\/\/doi.org\/10.1038\/nature09320","journal-title":"Nature"},{"issue":"4","key":"3294_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1212\/wnl.55.4.569","volume":"55","author":"M Fernandez","year":"2000","unstructured":"Fernandez M, McClain ME, Martinez RA, Snow K et al (2000) Late-onset SCA2: 33 CAG repeats are sufficient to cause disease. Neurology 55(4):569\u2013572. https:\/\/doi.org\/10.1212\/wnl.55.4.569","journal-title":"Neurology"},{"issue":"3","key":"3294_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/ng1196-269","volume":"14","author":"SM Pulst","year":"1996","unstructured":"Pulst SM, Nechiporuk A, Nechiporuk T, Gispert S et al (1996) Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 14(3):269\u2013276. https:\/\/doi.org\/10.1038\/ng1196-269","journal-title":"Nat Genet"},{"issue":"5","key":"3294_CR7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/hmg\/6.5.709","volume":"6","author":"G Cancel","year":"1997","unstructured":"Cancel G, D\u00fcrr A, Didierjean O, Imbert G et al (1997) Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum Mol Genet 6(5):709\u2013715. https:\/\/doi.org\/10.1093\/hmg\/6.5.709","journal-title":"Hum Mol Genet"},{"issue":"3","key":"3294_CR8","doi-asserted-by":"publisher","first-page":"e20190325","DOI":"10.1590\/1678-4685-gmb-2019-0325","volume":"43","author":"J S\u00e1nchez-Corona","year":"2020","unstructured":"S\u00e1nchez-Corona J, Ramirez-Garcia SA, Casta\u00f1eda-Cisneros G, Guti\u00e9rrez-Rubio SA et al (2020) A clinical report of the massive CAG repeat expansion in spinocerebellar ataxia type 2: Severe onset in a Mexican child and review previous cases. Genet Mol Biol 43(3):e20190325. https:\/\/doi.org\/10.1590\/1678-4685-gmb-2019-0325","journal-title":"Genet Mol Biol"},{"issue":"8","key":"3294_CR9","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1212\/wnl.44.8.1423","volume":"44","author":"S Belal","year":"1994","unstructured":"Belal S, Cancel G, Stevanin G, Hentati F et al (1994) Clinical and genetic analysis of a Tunisian family with autosomal dominant cerebellar ataxia type 1 linked to the SCA2 locus. Neurology 44(8):1423\u20131426. https:\/\/doi.org\/10.1212\/wnl.44.8.1423","journal-title":"Neurology"},{"issue":"Pt 6","key":"3294_CR10","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/brain\/118.6.1573","volume":"118","author":"A D\u00fcrr","year":"1995","unstructured":"D\u00fcrr A, Smadja D, Cancel G, Lezin A et al (1995) Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain 118(Pt 6):1573\u20131581. https:\/\/doi.org\/10.1093\/brain\/118.6.1573","journal-title":"Brain"},{"issue":"1","key":"3294_CR11","first-page":"12","volume":"3","author":"A D\u00fcrr","year":"1995","unstructured":"D\u00fcrr A, Brice A, Lepage-Lezin A, Cancel G et al (1995) Autosomal dominant cerebellar ataxia type I linked to chromosome 12q (SCA2: spinocerebellar ataxia type 2). Clin Neurosci 3(1):12\u201316","journal-title":"Clin Neurosci"},{"issue":"Pt 5","key":"3294_CR12","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/brain\/119.5.1497","volume":"119","author":"K B\u00fcrk","year":"1996","unstructured":"B\u00fcrk K, Abele M, Fetter M, Dichgans J et al (1996) Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain 119(Pt 5):1497\u20131505. https:\/\/doi.org\/10.1093\/brain\/119.5.1497","journal-title":"Brain"},{"issue":"9","key":"3294_CR13","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1212\/wnl.40.9.1369","volume":"40","author":"G Orozco Diaz","year":"1990","unstructured":"Orozco Diaz G, Nodarse Fleites A, Cordov\u00e9s Sagaz R, Auburger G (1990) Autosomal dominant cerebellar ataxia: clinical analysis of 263 patients from a homogeneous population in Holgu\u00edn Cuba. Neurology 40(9):1369\u20131375. https:\/\/doi.org\/10.1212\/wnl.40.9.1369","journal-title":"Neurology"},{"issue":"6","key":"3294_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s004150050385","volume":"246","author":"A Filla","year":"1999","unstructured":"Filla A, De Michele G, Santoro L, Calabrese O et al (1999) Spinocerebellar ataxia type 2 in southern Italy: a clinical and molecular study of 30 families. J Neurol 246(6):467\u2013471. https:\/\/doi.org\/10.1007\/s004150050385","journal-title":"J Neurol"},{"issue":"Pt 4","key":"3294_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/brain\/121.4.589","volume":"121","author":"T Klockgether","year":"1998","unstructured":"Klockgether T, L\u00fcdtke R, Kramer B, Abele M et al (1998) The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain 121(Pt 4):589\u2013600. https:\/\/doi.org\/10.1093\/brain\/121.4.589","journal-title":"Brain"},{"issue":"1","key":"3294_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12035-012-8348-8","volume":"47","author":"JJ Maga\u00f1a","year":"2013","unstructured":"Maga\u00f1a JJ, Vel\u00e1zquez-P\u00e9rez L, Cisneros B (2013) Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives. Mol Neurobiol 47(1):90\u2013104. https:\/\/doi.org\/10.1007\/s12035-012-8348-8","journal-title":"Mol Neurobiol"},{"issue":"9","key":"3294_CR17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/archneur.1997.00550210011007","volume":"54","author":"L Sch\u00f6ls","year":"1997","unstructured":"Sch\u00f6ls L, Gispert S, Vorgerd M, Menezes Vieira-Saecker AM et al (1997) Spinocerebellar ataxia type 2. Genotype and phenotype in German kindreds. Arch Neurol 54(9):1073\u20131080. https:\/\/doi.org\/10.1001\/archneur.1997.00550210011007","journal-title":"Arch Neurol"},{"issue":"3","key":"3294_CR18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s004010050989","volume":"97","author":"R Estrada","year":"1999","unstructured":"Estrada R, Galarraga J, Orozco G, Nodarse A et al (1999) Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies. Acta Neuropathol 97(3):306\u2013310. https:\/\/doi.org\/10.1007\/s004010050989","journal-title":"Acta Neuropathol"},{"issue":"Pt 12","key":"3294_CR19","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1093\/brain\/121.12.2341","volume":"121","author":"N Wadia","year":"1998","unstructured":"Wadia N, Pang J, Desai J, Mankodi A et al (1998) A clinicogenetic analysis of six Indian spinocerebellar ataxia (SCA2) pedigrees. The significance of slow saccades in diagnosis. Brain 121(Pt 12):2341\u20132355. https:\/\/doi.org\/10.1093\/brain\/121.12.2341","journal-title":"Brain"},{"issue":"1","key":"3294_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0022-510x(89)90159-7","volume":"93","author":"G Orozco","year":"1989","unstructured":"Orozco G, Estrada R, Perry TL, Ara\u00f1a J et al (1989) Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findings. J Neurol Sci 93(1):37\u201350. https:\/\/doi.org\/10.1016\/0022-510x(89)90159-7","journal-title":"J Neurol Sci"},{"issue":"Pt 3","key":"3294_CR21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/brain\/121.3.459","volume":"121","author":"P Giunti","year":"1998","unstructured":"Giunti P, Sabbadini G, Sweeney MG, Davis MB et al (1998) The role of the SCA2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families. Frequency, clinical and genetic correlates. Brain 121(Pt 3):459\u2013467. https:\/\/doi.org\/10.1093\/brain\/121.3.459","journal-title":"Brain"},{"issue":"3","key":"3294_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ng1196-285","volume":"14","author":"G Imbert","year":"1996","unstructured":"Imbert G, Saudou F, Yvert G, Devys D et al (1996) Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG\/glutamine repeats. Nat Genet 14(3):285\u2013291. https:\/\/doi.org\/10.1038\/ng1196-285","journal-title":"Nat Genet"},{"issue":"3","key":"3294_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/bpa.12412","volume":"27","author":"K Seidel","year":"2017","unstructured":"Seidel K, Siswanto S, Fredrich M, Bouzrou M et al (2017) On the distribution of intranuclear and cytoplasmic aggregates in the brainstem of patients with spinocerebellar ataxia type 2 and 3. Brain Pathol 27(3):345\u2013355. https:\/\/doi.org\/10.1111\/bpa.12412","journal-title":"Brain Pathol"},{"issue":"1","key":"3294_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/79162","volume":"26","author":"DP Huynh","year":"2000","unstructured":"Huynh DP, Figueroa K, Hoang N, Pulst SM (2000) Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat Genet 26(1):44\u201350. https:\/\/doi.org\/10.1038\/79162","journal-title":"Nat Genet"},{"issue":"15","key":"3294_CR25","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1111\/j.1432-1033.2004.04245.x","volume":"271","author":"M Albrecht","year":"2004","unstructured":"Albrecht M, Golatta M, W\u00fcllner U, Lengauer T (2004) Structural and functional analysis of ataxin-2 and ataxin-3. Eur J Biochem 271(15):3155\u20133170. https:\/\/doi.org\/10.1111\/j.1432-1033.2004.04245.x","journal-title":"Eur J Biochem"},{"issue":"1","key":"3294_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.expneurol.2008.09.020","volume":"215","author":"S van de Loo","year":"2009","unstructured":"van de Loo S, Eich F, Nonis D, Auburger G et al (2009) Ataxin-2 associates with rough endoplasmic reticulum. Exp Neurol 215(1):110\u2013118. https:\/\/doi.org\/10.1016\/j.expneurol.2008.09.020","journal-title":"Exp Neurol"},{"issue":"1","key":"3294_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jmb.2004.11.024","volume":"346","author":"M Ralser","year":"2005","unstructured":"Ralser M, Albrecht M, Nonhoff U, Lengauer T et al (2005) An integrative approach to gain insights into the cellular function of human ataxin-2. J Mol Biol 346(1):203\u2013214. https:\/\/doi.org\/10.1016\/j.jmb.2004.11.024","journal-title":"J Mol Biol"},{"issue":"9","key":"3294_CR28","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/hmg\/9.9.1303","volume":"9","author":"H Shibata","year":"2000","unstructured":"Shibata H, Huynh DP, Pulst SM (2000) A novel protein with RNA-binding motifs interacts with ataxin-2. Hum Mol Genet 9(9):1303\u20131313. https:\/\/doi.org\/10.1093\/hmg\/9.9.1303","journal-title":"Hum Mol Genet"},{"issue":"6","key":"3294_CR29","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00438-004-1090-9","volume":"272","author":"J Bravo","year":"2005","unstructured":"Bravo J, Aguilar-Henonin L, Olmedo G, Guzm\u00e1n P (2005) Four distinct classes of proteins as interaction partners of the PABC domain of Arabidopsis thaliana Poly(A)-binding proteins. Mol Genet Genomics 272(6):651\u2013665. https:\/\/doi.org\/10.1007\/s00438-004-1090-9","journal-title":"Mol Genet Genomics"},{"issue":"4","key":"3294_CR30","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1091\/mbc.e06-12-1120","volume":"18","author":"U Nonhoff","year":"2007","unstructured":"Nonhoff U, Ralser M, Welzel F, Piccini I et al (2007) Ataxin-2 interacts with the DEAD\/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules. Mol Biol Cell 18(4):1385\u20131396. https:\/\/doi.org\/10.1091\/mbc.e06-12-1120","journal-title":"Mol Biol Cell"},{"issue":"5","key":"3294_CR31","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/mds.21338","volume":"22","author":"HJ Freund","year":"2007","unstructured":"Freund HJ, Barnikol UB, Nolte D, Treuer H et al (2007) Subthalamic-thalamic DBS in a case with spinocerebellar ataxia type 2 and severe tremor-a unusual clinical benefit. Mov Disord 22(5):732\u2013735. https:\/\/doi.org\/10.1002\/mds.21338","journal-title":"Mov Disord"},{"issue":"11","key":"3294_CR32","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-H\u00fcbsch","year":"2006","unstructured":"Schmitz-H\u00fcbsch T, du Montcel ST, Baliko L, Berciano J et al (2006) Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66(11):1717\u20131720. https:\/\/doi.org\/10.1212\/01.wnl.0000219042.60538.92","journal-title":"Neurology"},{"key":"3294_CR33","doi-asserted-by":"publisher","first-page":"689938","DOI":"10.3389\/fnins.2021.689938","volume":"15","author":"A Yuan","year":"2021","unstructured":"Yuan A, Nixon RA (2021) Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies. Front Neurosci 15:689938. https:\/\/doi.org\/10.3389\/fnins.2021.689938","journal-title":"Front Neurosci"},{"issue":"7","key":"3294_CR34","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1007\/s00415-018-8893-9","volume":"265","author":"C Wilke","year":"2018","unstructured":"Wilke C, Bender F, Hayer SN, Brockmann K et al (2018) Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study. J Neurol 265(7):1618\u20131624. https:\/\/doi.org\/10.1007\/s00415-018-8893-9","journal-title":"J Neurol"},{"key":"3294_CR35","doi-asserted-by":"publisher","first-page":"105311","DOI":"10.1016\/j.nbd.2021.105311","volume":"153","author":"G Coarelli","year":"2021","unstructured":"Coarelli G, Darios F, Petit E, Dorgham K et al (2021) Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia. Neurobiol Dis 153:105311. https:\/\/doi.org\/10.1016\/j.nbd.2021.105311","journal-title":"Neurobiol Dis"},{"issue":"24","key":"3294_CR36","doi-asserted-by":"publisher","first-page":"e2404","DOI":"10.1212\/wnl.0000000000012945","volume":"97","author":"L Yang","year":"2021","unstructured":"Yang L, Shao YR, Li XY, Ma Y et al (2021) Association of the level of neurofilament light with disease severity in patients with spinocerebellar ataxia type 2. Neurology 97(24):e2404\u2013e2413. https:\/\/doi.org\/10.1212\/wnl.0000000000012945","journal-title":"Neurology"},{"key":"3294_CR37","doi-asserted-by":"publisher","first-page":"413098","DOI":"10.1155\/2015\/413098","volume":"2015","author":"AM Brouillette","year":"2015","unstructured":"Brouillette AM, \u00d6z G, Gomez CM (2015) Cerebrospinal fluid biomarkers in spinocerebellar ataxia: a pilot study. Dis Markers 2015:413098. https:\/\/doi.org\/10.1155\/2015\/413098","journal-title":"Dis Markers"},{"issue":"1","key":"3294_CR38","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s12311-011-0308-8","volume":"11","author":"BC Jung","year":"2012","unstructured":"Jung BC, Choi SI, Du AX, Cuzzocreo JL et al (2012) MRI shows a region-specific pattern of atrophy in spinocerebellar ataxia type 2. Cerebellum 11(1):272\u2013279. https:\/\/doi.org\/10.1007\/s12311-011-0308-8","journal-title":"Cerebellum"},{"key":"3294_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.pneurobio.2013.01.001","volume":"104","author":"U R\u00fcb","year":"2013","unstructured":"R\u00fcb U, Sch\u00f6ls L, Paulson H, Auburger G et al (2013) Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. Prog Neurobiol 104:38\u201366. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.01.001","journal-title":"Prog Neurobiol"},{"key":"3294_CR40","doi-asserted-by":"publisher","first-page":"616419","DOI":"10.3389\/fneur.2020.616419","volume":"11","author":"A Nigri","year":"2020","unstructured":"Nigri A, Sarro L, Mongelli A, Pinardi C et al (2020) Progression of cerebellar atrophy in spinocerebellar ataxia type 2 gene carriers: a longitudinal MRI study in preclinical and early disease stages. Front Neurol 11:616419. https:\/\/doi.org\/10.3389\/fneur.2020.616419","journal-title":"Front Neurol"},{"issue":"1","key":"3294_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ab.2009.08.001","volume":"395","author":"A Weiss","year":"2009","unstructured":"Weiss A, Abramowski D, Bibel M, Bodner R et al (2009) Single-step detection of mutant huntingtin in animal and human tissues: a bioassay for Huntington's disease. Anal Biochem 395(1):8\u201315. https:\/\/doi.org\/10.1016\/j.ab.2009.08.001","journal-title":"Anal Biochem"},{"issue":"10","key":"3294_CR42","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1172\/jci64565","volume":"122","author":"A Weiss","year":"2012","unstructured":"Weiss A, Tr\u00e4ger U, Wild EJ, Grueninger S et al (2012) Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression. J Clin Invest 122(10):3731\u20133736. https:\/\/doi.org\/10.1172\/jci64565","journal-title":"J Clin Invest"},{"issue":"2","key":"3294_CR43","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.chembiol.2011.12.020","volume":"19","author":"B Baldo","year":"2012","unstructured":"Baldo B, Paganetti P, Grueninger S, Marcellin D et al (2012) TR-FRET-based duplex immunoassay reveals an inverse correlation of soluble and aggregated mutant huntingtin in huntington's disease. Chem Biol 19(2):264\u2013275. https:\/\/doi.org\/10.1016\/j.chembiol.2011.12.020","journal-title":"Chem Biol"},{"issue":"4","key":"3294_CR44","doi-asserted-by":"publisher","first-page":"e62043","DOI":"10.1371\/journal.pone.0062043","volume":"8","author":"HP Nguyen","year":"2013","unstructured":"Nguyen HP, H\u00fcbener J, Weber JJ, Grueninger S et al (2013) Cerebellar soluble mutant ataxin-3 level decreases during disease progression in spinocerebellar ataxia type 3 mice. PLoS One 8(4):e62043. https:\/\/doi.org\/10.1371\/journal.pone.0062043","journal-title":"PLoS One"},{"issue":"4","key":"3294_CR45","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1007\/s00415-020-10274-y","volume":"268","author":"K Gonsior","year":"2021","unstructured":"Gonsior K, Kaucher GA, Pelz P, Schumann D et al (2021) PolyQ-expanded ataxin-3 protein levels in peripheral blood mononuclear cells correlate with clinical parameters in SCA3: a pilot study. J Neurol 268(4):1304\u20131315. https:\/\/doi.org\/10.1007\/s00415-020-10274-y","journal-title":"J Neurol"},{"issue":"5","key":"3294_CR46","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1172\/jci80743","volume":"125","author":"EJ Wild","year":"2015","unstructured":"Wild EJ, Boggio R, Langbehn D, Robertson N et al (2015) Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients. J Clin Invest 125(5):1979\u20131986. https:\/\/doi.org\/10.1172\/jci80743","journal-title":"J Clin Invest"},{"issue":"11","key":"3294_CR47","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1002\/mds.28749","volume":"36","author":"J H\u00fcbener-Schmid","year":"2021","unstructured":"H\u00fcbener-Schmid J, Kuhlbrodt K, Peladan J, Faber J et al (2021) Polyglutamine-expanded ataxin-3: a target engagement marker for spinocerebellar ataxia type 3 in peripheral blood. Mov Disord 36(11):2675. https:\/\/doi.org\/10.1002\/mds.28749","journal-title":"Mov Disord"},{"issue":"4","key":"3294_CR48","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/wco.0000000000000959","volume":"34","author":"JM Laffita-Mesa","year":"2021","unstructured":"Laffita-Mesa JM, Paucar M, Svenningsson P (2021) Ataxin-2 gene: a powerful modulator of neurological disorders. Curr Opin Neurol 34(4):578. https:\/\/doi.org\/10.1097\/wco.0000000000000959","journal-title":"Curr Opin Neurol"},{"issue":"Pt 12","key":"3294_CR49","doi-asserted-by":"publisher","first-page":"e398","DOI":"10.1093\/brain\/awv206","volume":"138","author":"M Raposo","year":"2015","unstructured":"Raposo M, Ramos A, Bettencourt C, Lima M (2015) Replicating studies of genetic modifiers in spinocerebellar ataxia type 3: can homogeneous cohorts aid? Brain 138(Pt 12):e398. https:\/\/doi.org\/10.1093\/brain\/awv206","journal-title":"Brain"},{"issue":"2","key":"3294_CR50","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ana.25409","volume":"85","author":"D Santos","year":"2019","unstructured":"Santos D, Coelho T, Alves-Ferreira M, Sequeiros J et al (2019) Large normal alleles of ATXN2 decrease age at onset in transthyretin familial amyloid polyneuropathy Val30Met patients. Ann Neurol 85(2):251\u2013258. https:\/\/doi.org\/10.1002\/ana.25409","journal-title":"Ann Neurol"},{"key":"3294_CR51","doi-asserted-by":"publisher","first-page":"231.e7","DOI":"10.1016\/j.neurobiolaging.2018.09.009","volume":"73","author":"E Rubino","year":"2019","unstructured":"Rubino E, Mancini C, Boschi S, Ferrero P et al (2019) ATXN2 intermediate repeat expansions influence the clinical phenotype in frontotemporal dementia. Neurobiol Aging 73:231.e7\u2013231.e9. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.09.009","journal-title":"Neurobiol Aging"},{"key":"3294_CR52","doi-asserted-by":"publisher","first-page":"139.e1","DOI":"10.1016\/j.neurobiolaging.2019.10.017","volume":"87","author":"I Rosas","year":"2020","unstructured":"Rosas I, Mart\u00ednez C, Clarim\u00f3n J, Lle\u00f3 A et al (2020) Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease. Neurobiol Aging 87:139.e1\u2013139.e7. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.10.017","journal-title":"Neurobiol Aging"},{"issue":"8","key":"3294_CR53","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/brain\/awac167","volume":"145","author":"JD Glass","year":"2022","unstructured":"Glass JD, Dewan R, Ding J, Gibbs JR et al (2022) ATXN2 intermediate expansions in amyotrophic lateral sclerosis. Brain. 145(8):2671\u20132676. https:\/\/doi.org\/10.1093\/brain\/awac167","journal-title":"Brain."},{"issue":"12","key":"3294_CR54","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.15252\/embj.201593350","volume":"35","author":"C Sellier","year":"2016","unstructured":"Sellier C, Campanari ML, Julie Corbier C, Gaucherot A et al (2016) Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. Embo J 35(12):1276\u20131297. https:\/\/doi.org\/10.15252\/embj.201593350","journal-title":"Embo J"},{"issue":"8","key":"3294_CR55","doi-asserted-by":"publisher","first-page":"e105534","DOI":"10.1371\/journal.pone.0105534","volume":"9","author":"MD Wang","year":"2014","unstructured":"Wang MD, Gomes J, Cashman NR, Little J et al (2014) Intermediate CAG repeat expansion in the ATXN2 gene is a unique genetic risk factor for ALS--a systematic review and meta-analysis of observational studies. PLoS One 9(8):e105534. https:\/\/doi.org\/10.1371\/journal.pone.0105534","journal-title":"PLoS One"},{"issue":"1","key":"3294_CR56","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40478-018-0547-8","volume":"6","author":"C Fournier","year":"2018","unstructured":"Fournier C, Anquetil V, Camuzat A, Stirati-Buron S et al (2018) Interrupted CAG expansions in ATXN2 gene expand the genetic spectrum of frontotemporal dementias. Acta Neuropathol Commun 6(1):41. https:\/\/doi.org\/10.1186\/s40478-018-0547-8","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"3294_CR57","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/mds.28334","volume":"36","author":"JM Laffita-Mesa","year":"2021","unstructured":"Laffita-Mesa JM, Nennesmo I, Paucar M, Svenningsson P (2021) A novel duplication in ATXN2 as modifier for spinocerebellar ataxia 3 (SCA3) and C9ORF72-ALS. Mov Disord 36(2):508\u2013514. https:\/\/doi.org\/10.1002\/mds.28334","journal-title":"Mov Disord"},{"issue":"8","key":"3294_CR58","doi-asserted-by":"publisher","first-page":"e1002920","DOI":"10.1371\/journal.pgen.1002920","volume":"8","author":"E Damrath","year":"2012","unstructured":"Damrath E, Heck MV, Gispert S, Azizov M et al (2012) ATXN2-CAG42 sequesters PABPC1 into insolubility and induces FBXW8 in cerebellum of old ataxic knock-in mice. PLoS Genet 8(8):e1002920. https:\/\/doi.org\/10.1371\/journal.pgen.1002920","journal-title":"PLoS Genet"},{"key":"3294_CR59","doi-asserted-by":"publisher","first-page":"104559","DOI":"10.1016\/j.nbd.2019.104559","volume":"132","author":"NE Sen","year":"2019","unstructured":"Sen NE, Canet-Pons J, Halbach MV, Arsovic A et al (2019) Generation of an Atxn2-CAG100 knock-in mouse reveals N-acetylaspartate production deficit due to early Nat8l dysregulation. Neurobiol Dis 132:104559. https:\/\/doi.org\/10.1016\/j.nbd.2019.104559","journal-title":"Neurobiol Dis"},{"issue":"2","key":"3294_CR60","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.scr.2016.09.011","volume":"17","author":"S Hauser","year":"2016","unstructured":"Hauser S, H\u00f6flinger P, Theurer Y, Rattay TW et al (2016) Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5). Stem Cell Res 17(2):437\u2013440. https:\/\/doi.org\/10.1016\/j.scr.2016.09.011","journal-title":"Stem Cell Res"},{"key":"3294_CR61","doi-asserted-by":"publisher","first-page":"544043","DOI":"10.3389\/fcell.2020.544043","volume":"8","author":"S Hauser","year":"2020","unstructured":"Hauser S, Schuster S, Heuten E, H\u00f6flinger P et al (2020) Comparative transcriptional profiling of motor neuron disorder-associated genes in various human cell culture models. Front Cell Dev Biol 8:544043. https:\/\/doi.org\/10.3389\/fcell.2020.544043","journal-title":"Front Cell Dev Biol"},{"key":"3294_CR62","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/abio.1976.9999","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254. https:\/\/doi.org\/10.1006\/abio.1976.9999","journal-title":"Anal Biochem"},{"issue":"5259","key":"3294_CR63","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259):680\u2013685. https:\/\/doi.org\/10.1038\/227680a0","journal-title":"Nature"},{"issue":"2","key":"3294_CR64","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0003-2697(81)90281-5","volume":"112","author":"WN Burnette","year":"1981","unstructured":"Burnette WN (1981) \"Western blotting\": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 112(2):195\u2013203. https:\/\/doi.org\/10.1016\/0003-2697(81)90281-5","journal-title":"Anal Biochem"},{"issue":"7","key":"3294_CR65","doi-asserted-by":"publisher","first-page":"e11803","DOI":"10.15252\/emmm.201911803","volume":"12","author":"C Wilke","year":"2020","unstructured":"Wilke C, Haas E, Reetz K, Faber J et al (2020) Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice. EMBO Mol Med 12(7):e11803. https:\/\/doi.org\/10.15252\/emmm.201911803","journal-title":"EMBO Mol Med"},{"issue":"8","key":"3294_CR66","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/nm1076","volume":"10","author":"H Xia","year":"2004","unstructured":"Xia H, Mao Q, Eliason SL, Harper SQ et al (2004) RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 10(8):816\u2013820. https:\/\/doi.org\/10.1038\/nm1076","journal-title":"Nat Med"},{"key":"3294_CR67","doi-asserted-by":"publisher","unstructured":"Friedrich J, Kordasiewicz HB, O'Callaghan B, Handler HP et al (2018) Antisense oligonucleotide-mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles. JCI. Insight 3(21). https:\/\/doi.org\/10.1172\/jci.insight.123193","DOI":"10.1172\/jci.insight.123193"},{"issue":"7650","key":"3294_CR68","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nature22044","volume":"544","author":"DR Scoles","year":"2017","unstructured":"Scoles DR, Meera P, Schneider MD, Paul S et al (2017) Antisense oligonucleotide therapy for spinocerebellar ataxia type 2. Nature 544(7650):362\u2013366. https:\/\/doi.org\/10.1038\/nature22044","journal-title":"Nature"},{"issue":"6","key":"3294_CR69","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","volume":"74","author":"HB Kordasiewicz","year":"2012","unstructured":"Kordasiewicz HB, Stanek LM, Wancewicz EV, Mazur C et al (2012) Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis. Neuron 74(6):1031\u20131044. https:\/\/doi.org\/10.1016\/j.neuron.2012.05.009","journal-title":"Neuron"},{"issue":"1","key":"3294_CR70","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1089\/nat.2013.0452","volume":"24","author":"MM Evers","year":"2014","unstructured":"Evers MM, Tran HD, Zalachoras I, Meijer OC et al (2014) Preventing formation of toxic N-terminal huntingtin fragments through antisense oligonucleotide-mediated protein modification. Nucleic Acid Ther 24(1):4\u201312. https:\/\/doi.org\/10.1089\/nat.2013.0452","journal-title":"Nucleic Acid Ther"},{"key":"3294_CR71","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.omtm.2019.10.008","volume":"15","author":"R Martier","year":"2019","unstructured":"Martier R, Sogorb-Gonzalez M, Stricker-Shaver J, H\u00fcbener-Schmid J et al (2019) Development of an AAV-based microRNA gene therapy to treat Machado-Joseph disease. Mol Ther Methods Clin Dev 15:343\u2013358. https:\/\/doi.org\/10.1016\/j.omtm.2019.10.008","journal-title":"Mol Ther Methods Clin Dev"},{"key":"3294_CR72","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.omtn.2017.04.005","volume":"7","author":"LR Moore","year":"2017","unstructured":"Moore LR, Rajpal G, Dillingham IT, Qutob M et al (2017) Evaluation of antisense oligonucleotides targeting ATXN3 in SCA3 mouse models. Mol Ther Nucleic Acids 7:200\u2013210. https:\/\/doi.org\/10.1016\/j.omtn.2017.04.005","journal-title":"Mol Ther Nucleic Acids"},{"key":"3294_CR73","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.nbd.2013.04.019","volume":"58","author":"MM Evers","year":"2013","unstructured":"Evers MM, Tran HD, Zalachoras I, Pepers BA et al (2013) Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon. Neurobiol Dis 58:49\u201356. https:\/\/doi.org\/10.1016\/j.nbd.2013.04.019","journal-title":"Neurobiol Dis"},{"key":"3294_CR74","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.omtn.2021.11.015","volume":"27","author":"S Hauser","year":"2022","unstructured":"Hauser S, Helm J, Kraft M, Korneck M et al (2022) Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons. Mol Ther Nucleic Acids 27:99\u2013108. https:\/\/doi.org\/10.1016\/j.omtn.2021.11.015","journal-title":"Mol Ther Nucleic Acids"},{"issue":"20","key":"3294_CR75","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1093\/hmg\/ddt273","volume":"22","author":"FA Klein","year":"2013","unstructured":"Klein FA, Zeder-Lutz G, Cousido-Siah A, Mitschler A et al (2013) Linear and extended: a common polyglutamine conformation recognized by the three antibodies MW1, 1C2 and 3B5H10. Hum Mol Genet 22(20):4215\u20134223. https:\/\/doi.org\/10.1093\/hmg\/ddt273","journal-title":"Hum Mol Genet"},{"issue":"1","key":"3294_CR76","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","volume":"5","author":"T Klockgether","year":"2019","unstructured":"Klockgether T, Mariotti C, Paulson HL (2019) Spinocerebellar ataxia. Nat Rev Dis Primers 5(1):24. https:\/\/doi.org\/10.1038\/s41572-019-0074-3","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"3294_CR77","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S, Hasz R, Walters G et al (2013) The Genotype-Tissue Expression (GTEx) project. Nat Genet 45(6):580\u2013585. https:\/\/doi.org\/10.1038\/ng.2653","journal-title":"Nat Genet"},{"key":"3294_CR78","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.bbadis.2016.05.017","volume":"9","author":"I Lastres-Becker","year":"1862","unstructured":"Lastres-Becker I, Nonis D, Eich F, Klinkenberg M et al (1862) (2016) Mammalian ataxin-2 modulates translation control at the pre-initiation complex via PI3K\/mTOR and is induced by starvation. Biochim Biophys Acta 9:1558\u20131569. https:\/\/doi.org\/10.1016\/j.bbadis.2016.05.017","journal-title":"Biochim Biophys Acta"},{"issue":"40","key":"3294_CR79","doi-asserted-by":"publisher","first-page":"33691","DOI":"10.1074\/jbc.M112.379792","volume":"287","author":"M Bidinosti","year":"2012","unstructured":"Bidinosti M, Shimshek DR, Mollenhauer B, Marcellin D et al (2012) Novel one-step immunoassays to quantify \u03b1-synuclein: applications for biomarker development and high-throughput screening. J Biol Chem 287(40):33691\u201333705. https:\/\/doi.org\/10.1074\/jbc.M112.379792","journal-title":"J Biol Chem"},{"issue":"6","key":"3294_CR80","doi-asserted-by":"publisher","first-page":"e0128769","DOI":"10.1371\/journal.pone.0128769","volume":"10","author":"DR Scoles","year":"2015","unstructured":"Scoles DR, Ho MH, Dansithong W, Pflieger LT et al (2015) Repeat associated non-AUG translation (RAN translation) dependent on sequence downstream of the ATXN2 CAG Repeat. PLoS One 10(6):e0128769. https:\/\/doi.org\/10.1371\/journal.pone.0128769","journal-title":"PLoS One"},{"key":"3294_CR81","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neulet.2014.01.046","volume":"563","author":"A Asada","year":"2014","unstructured":"Asada A, Yamazaki R, Kino Y, Saito T et al (2014) Cyclin-dependent kinase 5 phosphorylates and induces the degradation of ataxin-2. Neurosci Lett 563:112\u2013117. https:\/\/doi.org\/10.1016\/j.neulet.2014.01.046","journal-title":"Neurosci Lett"},{"key":"3294_CR82","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s42466-019-0025-1","volume":"1","author":"I Lastres-Becker","year":"2019","unstructured":"Lastres-Becker I, Nonis D, Nowock J, Auburger G (2019) New alternative splicing variants of the ATXN2 transcript. Neurol Res Pract 1:22. https:\/\/doi.org\/10.1186\/s42466-019-0025-1","journal-title":"Neurol Res Pract"},{"issue":"8","key":"3294_CR83","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1007\/s00415-021-10467-z","volume":"268","author":"R Inada","year":"2021","unstructured":"Inada R, Hirano M, Oka N, Samukawa M et al (2021) Phenotypic and molecular diversities of spinocerebellar ataxia type 2 in Japan. J Neurol 268(8):2933\u20132942. https:\/\/doi.org\/10.1007\/s00415-021-10467-z","journal-title":"J Neurol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03294-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03294-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03294-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T05:15:22Z","timestamp":1682140522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03294-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,9]]},"references-count":83,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3294"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03294-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2144417\/v1","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,9]]},"assertion":[{"value":"11 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical use of animals: All mice were maintained by animal care staff and veterinarians of the University of Frankfurt\/Main Zentrale Forschungs-Einrichtung (ZFE). All procedures were performed according to the German Animal Welfare Act and the guidelines of the Federation of European Laboratory Animal Science Associations, based on European Union legislation (Directive 2010\/63\/EU). Animal experiments were approved by the local ethics committee (Regierungs-Pr\u00e4sidium Darmstadt V54-19c18-FK\/1083).Ethical use of human tissue: All the work involving human tissue has been carried out in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki) and with national legislation as well as our institutional guidelines. Experiments were approved by the local ethics committee (ethical vote T\u00fcbingen, 598\/2011BO1 and 911\/2019BO2).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All patients gave written informed consent before enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All study participants agreed in publication of the data with the informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}